# HAUS BIOCEUTICALS INC: Form D filing

HAUS BIOCEUTICALS INC, a pharmaceuticals company in Oklahoma City, OK, filed a Form D with the SEC in 2012. The latest, on February 14, 2012, reports $150,000 sold of a $350,000 offering to 3 investors.

Find out what HAUS BIOCEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20HAUS%20BIOCEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=HAUS%20BIOCEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fhaus-bioceuticals-inc-1541491)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20HAUS%20BIOCEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=HAUS%20BIOCEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fhaus-bioceuticals-inc-1541491)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma): 227 rows, by operating companies, filed since November 1, 2024, $11.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oklahoma
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 755 RESEARCH PARKWAY, SUITE 460, Oklahoma City, OK, 73104
- Phone: (405) 295-5257
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 504
- SEC identifier (CIK): 1541491

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 14, 2012 | New notice | $350,000 | $150,000 | $200,000 | 3 | Feb 1, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1541491/000114036112007849/0001140361-12-007849-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| ADAM J. PAYNE | Executive Officer, Director |  |
| Michael J. Centola | Executive Officer, Director |  |
| Philip J. Alex | Director |  |

[Every Form D from the week of Feb 13, 2012](https://specstream.ai/data/form-d/week/2012-02-13) · [All recent filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what HAUS BIOCEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).